David G. Bonsall

According to our database, David G. Bonsall authored at least 4 papers between 2015 and 2021.

Collaborative distances:

• Dijkstra number of four.
• Erdős number of three.

2021

OpenABM-Covid19 - An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing.

Robert Hinch, William J. M. Probert, Anel Nurtay, Michelle Kendall, Chris Wymant, Matthew Hall, Katrina A. Lythgoe, Ana Bulas Cruz, Lele Zhao, Andrea Stewart, Luca Ferretti, Daniel Montero, James Warren, Nicole Mather, Matthew Abueg, Neo Wu, Olivier Legat, Katie Bentley, Thomas Mead, Kelvin Van-Vuuren, Dylan Feldner-Busztin, Tommaso Ristori, Anthony Finkelstein, David G. Bonsall, Lucie Abeler-Dörner, Christophe Fraser

PLoS Comput. Biol., 2021

Modeling the effect of exposure notification and non-pharmaceutical interventions on COVID-19 transmission in Washington state.

Matthew Abueg, Robert Hinch, Neo Wu, Luyang Liu, William J. M. Probert, Austin Wu, Paul Eastham, Yusef Shafi, Matt Rosencrantz, Michael Dikovsky, Zhao Cheng, Anel Nurtay, Lucie Abeler-Dörner, David G. Bonsall, Michael V. McConnell, Shawn O'Banion, Christophe Fraser

npj Digit. Medicine, 2021

Epidemiological and public health requirements for COVID-19 contact tracing apps and their evaluation.

Vittoria Colizza, Eva Grill, Rafael T. Mikolajczyk, Ciro Cattuto, Adam J. Kucharski, Steven Riley, Michelle Kendall, Katrina A. Lythgoe, Lucie Abeler-Dörner, Chris Wymant, David G. Bonsall, Luca Ferretti, Christophe Fraser

CoRR, 2021

2015

ve-SEQ: Robust, unbiased enrichment for streamlined detection and whole-genome sequencing of HCV and other highly diverse pathogens.

David G. Bonsall, M. Azim Ansari, Camilla Ip, Amy Trebes, Anthony Brown, Paul Klenerman, David Buck, STOP-HCV Consortium, Paolo Piazza, Eleanor Barnes, Rory J. Bowden

F1000Research, 2015